Nanoencapsulation of Hirudo medicinalis proteins in liposomes as a nanocarrier for inhibiting angiogenesis through targeting VEGFA in the Breast cancer cell line (MCF-7)

被引:8
作者
Shakouri, Amir [1 ,2 ]
Kahroba, Houman [2 ]
Hamishekar, Hamed [1 ]
Abdolalizadeh, Jalal [3 ,4 ]
机构
[1] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Mol Med, Tabriz, Iran
[3] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[4] Tabriz Univ Med Sci, Paramed Fac, Tabriz, Iran
关键词
Angiogenesis; Breast cancer; Leech saliva extract; Liposome; Nano drug; VEGFA; DELIVERY; ENCAPSULATION; THERAPY; LEECH;
D O I
10.34172/bi.2021.39
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Breast cancer is the most serious cause of women's death throughout the world. Using nanocarrier vehicles to the exact site of cancer upgrades the therapeutic efficiency of the drugs. Capsulation of active proteins in the vesicular liposomes' hydrophilic core is essential to develop a therapeutic protein carrier system. We aimed to encapsulate the medicinal leech saliva extract (LSE) and assess the inhibition of angiogenesis of breast cancer cells by targeting vascular endothelial growth factor A (VEGFA). Methods: In this research, enhanced formulation of liposomal protein was determined by zeta potential analysis, droplet size, drug release assay, and transmission electron microscopy (TEM). Furthermore, a cytotoxicity assay of liposomal LSE was performed to determine the cytotoxic activity of components. For assessing the expression of VEGFA, P53, and hypoxia-inducible factor subunit alpha (HIF1a) genes, Real-Time PCR was applied. Results: Nano liposome was chosen as an enhanced formulation due to its much smaller size (46.23 nm). Liposomal LSE had more practical actions on the MCF-7 cells. As noticed by DAPI staining, apoptosis was extensively greater in treated MCF-7 cells. Wound healing assay demonstrated that MCF-7 cells could not sustain growth at the presence of liposomal LSE and expression of the VEGFA gene was declined in treated cells. Downregulation of VEGFA was evaluated with western blotting technique. Conclusion: It can be concluded that our investigation of the tests confirmed the fact that nano liposomal LSE is a novel promising formulation for anticancer drugs and can significantly improve the penetration of protein drugs to cancer cells.
引用
收藏
页码:115 / 126
页数:12
相关论文
共 57 条
  • [1] Enhanced protein internalization and efficient endosomal escape using polyampholyte-modified liposomes and freeze concentration
    Ahmed, Sana
    Fujitab, Satoshi
    Matsumura, Kazuaki
    [J]. NANOSCALE, 2016, 8 (35) : 15888 - 15901
  • [2] Alaama M, 2011, IIUM ENG J, V12, P51
  • [3] Ammar A, 2017, MECH ANTICANCER ACTI
  • [4] Liposomal nanocarriers for statins: A pharmacokinetic and pharmacodynamics appraisal
    Askarizadeh, Anis
    Butler, Alexandra E.
    Badiee, Ali
    Sahebkar, Amirhossein
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (02) : 1219 - 1229
  • [5] Formulation and ex vivo evaluation of polymeric nanoparticles for controlled delivery of corticosteroids to the skin and the corneal epithelium
    Balzus, Benjamin
    Sahle, Fitsum Feleke
    Hoenzke, Stefan
    Gerecke, Christian
    Schumacher, Fabian
    Hedtrich, Sarah
    Kleuser, Burkhard
    Bodmeier, Roland
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2017, 115 : 122 - 130
  • [6] BANGHAM AD, 1963, ADV LIPID RES, V1, P65
  • [7] Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer
    Barar, Jaleh
    Omidi, Yadollah
    [J]. BIOIMPACTS, 2014, 4 (01) : 3 - 14
  • [8] Estrogen receptor agonists/antagonists in breast cancer therapy: A critical review
    Begam, A. Jameera
    Jubie, S.
    Nanjan, M. J.
    [J]. BIOORGANIC CHEMISTRY, 2017, 71 : 257 - 274
  • [9] Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
    Belfiore, Lisa
    Saunders, Darren N.
    Ranson, Marie
    Thurecht, Kristofer J.
    Storm, Gert
    Vine, Kara L.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2018, 277 : 1 - 13
  • [10] Chen MJ, 2017, GOOGLE PATENTS